My current post is Clinical Lead Pharmacist at the North Wales Cancer Treatment Centre, based at Glan Clwyd Hospital in North Wales. I graduated from Cardiff University in 1995, and completed my pre-reg and diploma residency at Bradford Hospitals NHS Trust before moving into a specialist haematology and oncology role. I completed my MSc research project into quality of life during chemotherapy for colorectal cancer. In 2001 I moved to the Christie Hospital to facilitate PGDs and nurse prescribing. For my clinical role I supported the breast and ovarian cancer medical oncology clinics. During my final year at the Christie I spent most of my time working on 2 projects, electronic prescribing and the implementation of adjuvant trastuzumab therapy via homecare. In 2006 I took up my current post in North Wales, with a return to more general clinical pharmacy, supporting the haematology team in terms of new product/regimen introduction. I am an independent prescriber and continue to support nurse prescribers where possible. 

Netty graduated from The School of Pharmacy, University of London in 2001, and her first job was a rotational pharmacist in Broomfield Hospital, Chelmsford, where her interest in oncology and haematology was born. In 2004, she took up the role of Senior Cancer Pharmacist at Colchester Hospital, where she gained experience in web design and management, project management and clinical oncology. It was in early 2006, that she was enlisted to project manage the re-design of the BOPA website by the Committee. Netty was the Lead Pharmacist for Essex Cancer Network from 2008 to 2013. She is now currently the Lead Pharmacist for e-prescribing in her local district general hospital and works for the Anglia Area Team as a cancer pharmacist. Netty is currently undertaking the MSc in Clinical Oncology.

Louise is currently working as Pharmacy Site Lead and Cancer Pharmacist at Barts Hospital. In this post she is responsible for chemotherapy and clinical trial services.Louise began her career in oncology at Barts Health in 2003 but undertook a 6 month secondment to Guys and St Thomas' Hospital in 2010.

Louise graduated in 1998 and has had jobs in the South West of England and Australia prior to moving to the 'Big Smoke'. She has also worked with the School of Pharmacy leading the postgraduate oncology diploma module. 

David's current role is that of Lead Pharmacist for the Yorkshire Cancer Network, where he has worked full time since October 2004.

He graduated from Strathclyde University in 1996 and his first job was as a resident pharmacist at the Royal Infirmary of Edinburgh. His interest in oncology/haematology grew from his second post at the Western General Infirmary in Edinburgh as a Rotational C Grade Clinical Pharmacist. During this time he rotated through the posts of Oncology/Haematology Outpatient and also Breast Services Pharmacist. In 2001, he moved to Leeds and took up the role of Lead Pharmacist for Haematology at the Leeds Teaching Hospitals NHS Trust. 

He was elected Chair of the Cancer Network Pharmacists Forum (CNPF) in October 2005 and continued in that role until October 2008 when he became Chair of BOPA.

I have worked in cancer services for more than 25 years, with experience managing aseptic units in DGHs and developing oncology pharmacy services at two Cancer Centres. I am currently the Macmillan Cancer network Pharmacist for the South East London Cancer Network (SELCN) and Lead Cancer Pharmacist for Guy’s and St Thomas’ NHS Foundation Trust. I undertook my Masters in Clinical Oncology in 1996 while working at Great Ormond Street Children’s Hospital and am an honorary lecturer at King’s College London. I am a member of the London Cancer New Drugs Group and working in partnership with the SELCN Management team and the team of Network Pharmacists in London, I have been instrumental in developing a process recommending the managed entry of new cancer medicines into clinical practice, to commissioners in London. In recent years this work has directly informed the implementation of the Cancer Drugs Fund for London. I am currently chair of the Cancer Network Pharmacists Forum.

I am currently the Lead Oncology and Hematology Pharmacist the Norfolk and Norwich University Hospital, a post I have held since 2002. I originally qualified in Melbourne and have worked as a hospital pharmacist in various posts in the UK since 1990. Prior to my current post I was Aseptic Services Manager & Principal Oncology Pharmacist at Northampton General Hospital and before that Specialist Radiopharmacist at Leeds General Infirmary.  While in Norwich I have completed an MSc in Oncology and acted as lead pharmacist for the former Norfolk and Waveney Cancer Network. I am currently the Chair of the East Anglian Oncology Pharmacists Group and an Associate Tutor at the University of East Anglia.

I recently joined the BOPA committee to represent the views of paediatric oncology pharmacists, having been a steering group committee member of the POP (paediatric oncology pharmacists) Group since it's formation in 1996. I am Principal Pharmacist for Clinical Services at the Royal Marsden NHS Trust, based at Sutton but with cross site responsibilities at RMH Chelsea. The Royal Marsden NHS Trust is part of the SW London Network. I graduated from the Leicester School of Pharmacy in 1979. After completing my pre-reg at King's College Hospital, and basic grade pharmacist posts at Westminster and National Heart/Brompton Hospitals, I joined the Royal Marsden in 1983, gaining promotion into my present post in 1989.

Succinct Healthcare Communications is a medical education and communications agency supporting the pharmaceutical industry and the NHS. Succinct specialises in oncology and haematology and provides numerous services, including strategic consultancy, KOL development, events and meetings management, publishing, e-media/digital services and market access support.

I started career in aseptic services as a basic grade at the University of Birmingham Hospital in 2007 then specialized in aseptics and oncology at Guys and St Thomas's hospital. My interest in Cancer services stemmed from here and I am currently the Lead Cancer services Pharmacist at Walsall healthcare NHS.

Ricardo Martinez Moreno-Davila is the Superintendent Pharmacist for Calea UK - Fresenius Kabi UK —European leader in infusion therapy, transfusion technology and clinical nutrition. He is responsible for pharmaceutical services provided for patients at home all over the UK . He graduated in Granada University in 2001, where he did postgraduate studies in Pharmaceutical Care. In 2002 he was recruited by Lloydspharmacy, and he worked in the East Yorkshire region in community pharmacy as Pharmacist and then as District Manager, where he developed a special interest in care for the elderly and pain management. In 2005 he went to work for Healthcare at Home Ltd in several positions. He specialised as Oncology Pharmacist, finishing in 2008 the Postgraduate Diploma in Clinical Oncology at the University of Birmingham . In 2010 he worked for Heart of England NHS Foundation trust as a Lead Oncology and Aseptic Services Pharmacist, then in September 2011 he came back to work for Healthcare At Home Ltd as the Lead Oncology Pharmacist for Healthcare at Home Ltd. Within the company, he was responsible for pharmaceutical services provided for oncology patients and was involved in projects such as oral oncology services and electronic prescribing.

Carl is the Lead Pharmacist for Cancer Services and Clinical Trials at Airedale NHS Foundation Trust, based at Airedale General Hospital in West Yorkshire.

He graduated from Bradford University in 1990, worked in various hospital around West Yorkshire, and has been in his current post since 2000. Carl is responsible for clincal pharmacy services to all cancer patients, but specialises in mainly in oncology. He has been an independent prescriber for many years and was instrumental in setting up the innovative chemotherapy consent clinic, a multidisciplinary clinic for patients embarking on new chemotherapy.

Carl has presented several posters at previous BOPA symposia and was awarded the prize for best poster discussion in Glasgow in 2011, using the award to fund attendance at ESMO in 2012 and presenting an update to the symposium in 2012. This success motivated Carl to stand for the BOPA Committee in order to represent cancer specialist pharmacists from smaller Trusts and District General Hospitals, and to encourage research, audit and publication from other BOPA members.